We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.49B
AUM Growth
+$51.2M
Cap. Flow
-$31.6M
Cap. Flow %
-2.12%
Top 10 Hldgs %
36.37%
Holding
159
New
26
Increased
22
Reduced
60
Closed
36

Sector Composition

Rank Sector Weight
1 Technology 23.5%
2 Financials 18.64%
3 Consumer Discretionary 18.2%
4 Healthcare 18.05%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
26
Salesforce
CRM
$210B
$20.3M 1.36%
216,900
+112,000
+107% +$10.3M
ALGN icon
27
Align Technology
ALGN
$10.4B
$18.7M 1.25%
100,165
-28,000
-22% -$4.79M
SLRC icon
28
SLR Investment Corp
SLRC
$658M
$17.8M 1.2%
824,831
-258,300
-24% -$5.56M
JD icon
29
JD.com
JD
$36.6B
$17.6M 1.18%
+459,600
New +$19.7M
BIIB icon
30
Biogen
BIIB
$31.9B
$16.5M 1.11%
52,672
-550
-1% -$163K
SNNA
31
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$16.4M 1.1%
+751,209
New +$16.5M
PMT
32
PennyMac Mortgage Investment
PMT
$783M
$15.9M 1.07%
914,272
-487,000
-35% -$8.48M
LEN icon
33
Lennar Class A
LEN
$19.3B
$14.8M 0.99%
294,154
-9,875
-3% -$492K
MU icon
34
Micron Technology
MU
$1.05T
$14.2M 0.95%
+360,200
New +$11.4M
CRSP icon
35
CRISPR Therapeutics
CRSP
$5.01B
$13.9M 0.93%
779,931
-17,300
-2% -$314K
LOGM
36
DELISTED
LogMein, Inc.
LOGM
$13.7M 0.92%
124,424
-6,110
-5% -$685K
UHAL icon
37
U-Haul Holding Co
UHAL
$12.3B
$13.3M 0.89%
356,100
-375,000
-51% -$14M
PFE icon
38
Pfizer
PFE
$157B
$12.9M 0.87%
381,232
GBDC icon
39
Golub Capital BDC
GBDC
$3.23B
$12.8M 0.86%
693,939
-291,598
-30% -$5.44M
TCOM icon
40
Trip.com Group
TCOM
$24.7B
$12.8M 0.86%
+242,370
New +$13.2M
BMY icon
41
Bristol-Myers Squibb
BMY
$130B
$12.5M 0.84%
195,960
-158,400
-45% -$9.25M
CVNA icon
42
Carvana
CVNA
$48.2B
$11.3M 0.76%
3,848,250
+3,373,000
+710% +$12.3M
LADR
43
Ladder Capital
LADR
$1.21B
$11M 0.74%
796,778
-267,200
-25% -$3.59M
ALXN
44
DELISTED
Alexion Pharmaceuticals
ALXN
$10.9M 0.73%
77,359
-64,500
-45% -$8.76M
ITCI
45
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.4M 0.7%
658,750
+281,900
+75% +$4.14M
CELG
46
DELISTED
Celgene Corp
CELG
$10.3M 0.69%
70,847
-37,900
-35% -$5.16M
BIDU icon
47
Baidu
BIDU
$30.8B
$9.89M 0.66%
39,924
-38,550
-49% -$8.41M
BIVV
48
DELISTED
Bioverativ Inc. Common Stock
BIVV
$9.75M 0.65%
170,900
-25,300
-13% -$1.48M
ELLI
49
DELISTED
Ellie Mae Inc
ELLI
$9.62M 0.64%
117,100
-3,200
-3% -$294K
BEN icon
50
Franklin Templeton
BEN
$16.9B
$9.6M 0.64%
215,600
+88,500
+70% +$3.88M

Similar funds

Clough Capital Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Clough Capital Partners held 159 positions worth $1.49B, up 3.5% from $1.44B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners's Q3 2017 filing shows 26 new, 22 increased, 60 reduced and 36 closed positions. Its largest new stake was Cypress Semiconductor: 1,695,300 shares worth $25.5M. The largest sale was Western Digital, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Clough Capital Partners's largest Q3 2017 buy was Cypress Semiconductor: 1,695,300 shares worth $25.5M.
  • Clough Capital Partners added most to Lam Research in Q3 2017, an estimated $32.7M increase.
  • Clough Capital Partners's biggest Q3 2017 reduction was Apple, cutting an estimated $19.2M.
  • Clough Capital Partners fully exited Western Digital in Q3 2017, selling an estimated $26.7M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $1.49B portfolio in Q3 2017.
  • Clough Capital Partners opened 26 new positions and closed 36 in Q3 2017.
  • Clough Capital Partners's portfolio value rose 3.5% quarter-over-quarter to $1.49B.

Based on Clough Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.